http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a62d8cdeb2cd0a6cd8574b3bb6d8104b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Marais |
| name | Richard Marais |
| given-name | Richard |
| organization-name | Authors' Affiliations: 1Cancer Research UK and EPSRC Cancer Imaging Centre, Division of Radiotherapy and Imaging, 2Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey; 3Division of Imaging Sciences and Biomedical Engineering, The Rayne Institute, St. Thomas' Hospital, London; and 4Cancer Research UK Centre for Cell and Molecular Biology, Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom 5Signal Transduction Laboratory, Institute of Cancer Research, London, United Kingdom; and Cancer Research UK Centre for Cell and Molecular Biology, Institute of Cancer Research, London SW3 6JB, United Kingdom 2Division of Cancer Biology, The Institute of Cancer Research, Chester Beatty Laboratories, London, United Kingdom.; 3Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom. Authors' Affiliations: 1Department of Biochemistry, University of Leicester, Leicester, United Kingdom and 2Signal Transduction Team, Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, London, United Kingdom 3Cancer Research UK Centre for Cell and Molecular Biology, Institute of Cancer Research, London, United Kingdom Section of Cell and Molecular Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. 1The Institute of Cancer Research, Signal Transduction Team, Cancer Research UK Centre for Cell and Molecular Biology, London, United Kingdom; 2Cell and Molecular Biology, Institute of Cancer Research, London, United Kingdom; Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K., Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, U.K., and Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Park, Cambridge CB4 0QA, U.K. CR−UK Centre for Cancer Therapeutics at the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK Authors' Affiliations: 1Signal Transduction Team and 2Molecular Pathology/The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom CRUK Manchester Institute, University of Manchester, Manchester M20 4BX, UK,. Authors' Affiliations: 1Signal Transduction Team, The Institute of Cancer Research, London; 2Gene and Oncogene Targeting Team, Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Surrey; 3Molecular Oncology Group, The Paterson Institute for Cancer Research, Manchester, United Kingdom; Departments of 4Pathology and 5Neurology, Canisius Wilhelmina Hospital; Departments of 6Pathology and 7Neurology, Radboud University Nijmegen Medical Centre, Nijmegen; 8Department of Neurology, Reinier De Graaf Hospital, Delft; and 9Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands; Authors' Affiliations: 1Signal Transduction Team, The Institute of Cancer Research, London; 2Gene and Oncogene Targeting Team, Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Surrey; 3Molecular Oncology Group, The Paterson Institute for Cancer Research, Manchester, United Kingdom; Departments of 4Pathology and 5Neurology, Canisius Wilhelmina Hospital; Departments of 6Pathology and 7Neurology, Radboud University Nijmegen Medical Centre, Nijmegen; 8Department of Neurology, Reinier De Graaf Hospital, Delft; and 9Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands Authors' Affiliations: 1Signal Transduction Team, Section of Cell and Molecular Biology, 2Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom; and 3Gene and Oncogene Targeting Team, Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom Molecular Oncology Team, Cancer Research UK Manchester Institute, University of Manchester, Alderley Park, Macclesfield SK10 4TG, United Kingdom 3Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, London, United Kingdom Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB, United Kingdom Facultad de Medicina, Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas-IDICAN-Universidad de Cantabria, Santander, 39011 Cantabria, Spain; Institute of Cancer Research, Cancer Research UK Centre for Cell and Molecular Biology, 237 Fulham Road, London SW3 6JB, United Kingdom Authors' Affiliation: Signal Transduction Team, Division of Tumour Biology, The Institute of Cancer Research, London, United Kingdom CRC Centre for Cell and Molecular Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. 1Signal Transduction Team, Cancer Research UK Centre of Cell and Molecular Biology, The Institute of Cancer Research, London, United Kingdom and Molecular Oncology Group CRUK Manchester Institute University of Manchester Manchester UK Department of Nephrology, Dialysis and Organ Transplantation CHU Rangueil Toulouse France Authors' Affiliations: 1The Cancer Research UK Manchester Institute, Manchester; 2The Institute of Cancer Research, London, United Kingdom; 3Platform of Molecular Biology Facilities, Translational Research Department and Departments of 4Ophthalmological Surgery and 5Medical Oncology, 6Institut Curie; 7INSERM U830; and 8GenoSplice, Hopital Saint-Louis, Paris, France Authors' Affiliation: Molecular Oncology Group, The Paterson Institute for Cancer Research, The University of Manchester, Manchester, United Kingdom The Institute of Cancer Research, Cancer Research UK Centre for Cell and Molecular Biology, 237 Fulham Road, London SW3 6JB, United Kingdom Cancer Research UK Manchester Institute The University of Manchester Manchester UK 2Cancer Research UK Centre for Cell and Molecular Biology at The Institute of Cancer Research, London, United Kingdom; and Molecular Oncology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, United Kingdom. 3Signal Transduction Team, Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, London, United Kingdom CRC Centre for Cell and Molecular Biology, Institute of Cancer Research, London SW3 6JB, United Kingdom 2Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom. Authors' Affiliations: 1Department of Physiological Chemistry and Center for Biomedical Genetics, University Medical Center Utrecht; 2Department Pathobiology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; and 3Signal Transduction Team, Cancer Research UK Centre of Cell and Molecular Biology, Institute of Cancer Research, London, United Kingdom Department of Medical Biophysics, University of Toronto Authors' Affiliations: 1Genetics Division, Department of Medicine, 2Department of Pathology, Brigham and Women's Hospital; 3Harvard Medical School; 4Divisions of Surgical Oncology and Medical Oncology and Department of Dermatology, Massachusetts General Hospital; 5Ludwig Center at Dana-Farber/Harvard Cancer Center, Boston, Massachusetts; 6Department of Genetics, Medical Genomics Laboratory, University of Alabama at Birmingham, Birmingham, Alabama; 7Cancer Research Institute; 8Department of Cell and Molecular Pharmacology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and 9The Paterson Institute for Cancer Research, The University of Manchester, Manchester, United Kingdom Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom 2Cell and Molecular Biology, London, United Kingdom; and The Institute of Cancer Research, UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom, The Institute of Cancer Research, UK Centre for Cell and Molecular Biology, 237 Fulham Road, London SW3 6JB, United Kingdom, and Astex Therapeutics Ltd., 436 Cambridge Science Park, Cambridge CB4 0QA, United Kingdom The Institute of Cancer Research, Signal Transduction Team, Section of Cell and Molecular Biology, 237 Fulham Road, London, SW3 6JB, UK Authors' Affiliation: 1Division of Tumour Biology, The Institute of Cancer Research, London; and 2The Paterson Institute for Cancer Research, The University of Manchester, Manchester, United Kingdom.; Authors' Affiliation: 1Division of Tumour Biology, The Institute of Cancer Research, London; and 2The Paterson Institute for Cancer Research, The University of Manchester, Manchester, United Kingdom. 2The Institute of Cancer Research, Cancer Research UK Centre for Cell and Molecular Biology, London, United Kingdom Institute of Cancer Research, London SW3 6JB, United Kingdom 1Molecular Oncology Group, Cancer Research UK Manchester Institute, Manchester, United Kingdom. 2Cancer Research UK Manchester Institute, Manchester, United Kingdom. Molecular Oncology Group Cancer Research UK Manchester Institute Wilmslow Road Manchester M20 4BX UK Molecular Oncology Group CRUK Manchester Institute University of Manchester UK Authors' Affiliations: 1Signal Transduction Team and 2Cell Communication Team, The Institute of Cancer Research; 3Skin Unit and 4Melanoma Unit, Royal Marsden Hospital, London; 5Gene and Oncogene Targeting Team, CR-UK Cancer Therapeutics Unit, The Institute of Cancer Research, Surrey; 6Molecular Oncology Laboratory, The Paterson Institute for Cancer Research, The University of Manchester; and 7Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Authors' Affiliations: 1Signal Transduction Team and 2Cell Communication Team, The Institute of Cancer Research; 3Skin Unit and 4Melanoma Unit, Royal Marsden Hospital, London; 5Gene and Oncogene Targeting Team, CR-UK Cancer Therapeutics Unit, The Institute of Cancer Research, Surrey; 6Molecular Oncology Laboratory, The Paterson Institute for Cancer Research, The University of Manchester; and 7Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom Cancer Research UK Centre for Cancer Therapeutics at the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom Signal Transduction Team, Cancer Research UK Centre of Cell and Molecular Biology, The Institute of Cancer Research, London SW3 6JB, England, UK CRC Centre for Cancer Therapeutics, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K. 10Cancer Research UK Manchester Institute, University of Manchester, Manchester, United Kingdom. Molecular Oncology Group Cancer Research UK Manchester Institute Manchester UK CRC Centre for Cancer Therapeutics at the Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom, and CRC Centre for Cells Molecular Biology at the Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom Molecular Oncology Group Cancer Research UK Manchester Institute The University of Manchester Manchester UK 1Signal Transduction Team, Cancer Research UK Centre of Cell and Molecular Biology, The Institute of Cancer Research, London, United Kingdom, and Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK. Authors' Affiliations: 1The Paterson Institute for Cancer Research, Manchester, United Kingdom; 2Novartis Institute for Biomedical Research, Cambridge; and 3Dana Farber Cancer Institute, Boston, Massachusetts Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK.; Signal Transduction Team, The Institute of Cancer Research, London SW3 6JB, UK. 1Signal Transduction Team, The Institute for Cancer Research, Cancer Research UK Centre of Cell and Molecular Biology, London, United Kingdom, 1The Institute of Cancer Research, Signal Transduction Team, Cancer Research UK Centre of Cell and Molecular Biology, London, United Kingdom and The Institute of Cancer Research, Cancer Research UK Centre for Cancer Therapeutics, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom The Paterson Institute for Cancer Research, Manchester, United Kingdom Signal Transduction Team, The Institute of Cancer Research, Cancer Research UK Centre of Cell and Molecular Biology, London, UK Cancer Research UK Manchester Institute Withington Manchester UK Cancer Research UK Manchester Institute, The University of Manchester, Wilmslow Road, Withington, Manchester, United Kingdom CRC Center for Cell and Molecular Biology, Institute of Cancer Research, London SW3 6JB, United Kingdom Institute for Cancer Research, London SW3 6JB, United Kingdom; |
Incoming Links
Total number of triples: 257.